Evolution of the Transdermal Market: Mergers, Diversification, and Business Opportunities in a Transforming Segment

Transdermal patches have come a long way since their introduction in 1979. However, unlike other pharmaceutical forms, they never achieved massive market penetration: between 2015 and 2022, the FDA approved only 84 transdermal patches out of a total of 7,239 generic products, representing just 1.2% of the total. The reason [...]

Read More